Mahendra Pal

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Vedang Murthy, Priyamvada Maitre, Sadhana Kannan et al. · Journal of Clinical Oncology · 2021 · 327 citations

Medicine, Oncology, Urology +17

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 289 citations · Full text

Medicine, Oncology, Surgery +11

Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial

Vedang Murthy, Priyamvada Maitre, Jatin Bhatia et al. · Radiotherapy and Oncology · 2020 · 70 citations

Medicine, Radiation Oncology, Urology +17

Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation

Vedang Murthy, Priyamvada Gupta, K. Baruah et al. · Clinical Oncology · 2019 · 31 citations

Medicine, Radiation Oncology, Urology +14

Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)

Indranil Mallick, Abhilash Gavarraju, Shwetabh Sinha et al. · BMJ Open · 2020 · 31 citations · Full text

Medicine, Radiation Oncology, Urology +16